Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Aurora M Rojo"'
Publikováno v:
Expert Review of Clinical Pharmacology. 11:561-570
Triple combinations of antiretroviral therapy (ART) drugs are the standard treatment for human immunodeficiency virus (HIV) infection, but the challenges include long-term side effects, high costs, and adherence. The recent advent of potent and well-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::288acd27464355efd4eebf9238e3a81d
https://doi.org/10.1080/17512433.2018.1478726
https://doi.org/10.1080/17512433.2018.1478726
Autor:
José L. Casado, María Fontecha, Aurora M Rojo, Marta Monsalvo, María J Vivancos, Pilar Vizcarra
Publikováno v:
Antiviral therapy. 24(6)
Background Dual therapies decrease toxicity, pill-burden and treatment-associated cost. The combination of high genetic barrier drugs such as dolutegravir plus boosted-darunavir may be suitable as simplification regimen for patients harbouring multid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37395b2a573bb01ea4b980062ad84287
https://pubmed.ncbi.nlm.nih.gov/31172977
https://pubmed.ncbi.nlm.nih.gov/31172977
Autor:
Eva Delgado-Silveira, Sagrario Martín-Aragón, Aurora M. Rojo-Sanchís, Andrea Correa-Pérez, Alfonso J. Cruz-Jentoft
Publikováno v:
Aging clinical and experimental research. 31(7)
Polypharmacy and fall-risk increasing drugs (FRIDS) have been associated with injurious falls. We aimed to estimate the prevalence of polypharmacy and FRIDS in older patients discharged from an Orthogeriatric Unit after a hip fracture surgery.This st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1905515ff0cfe78fabd065f2e51d7b16
https://pubmed.ncbi.nlm.nih.gov/30276631
https://pubmed.ncbi.nlm.nih.gov/30276631
Autor:
Aurora M, Rojo-Sanchís, Manuel, Vélez-Díaz-Pallarés, María, Muñoz García, Eva, Delgado Silveira, Teresa, Bermejo Vicedo, Alfonso, Cruz Jentoft
Publikováno v:
Revista espanola de geriatria y gerontologia. 51(4)
The use of anticholinergic drugs in the elderly has been associated to an increased frequency of delirium. There are different scales for estimating the anticholinergic burden, such as the Anticholinergic Drug Scale (ADS), Anticholinergic Risk Scale
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9fd7eda39742c591c9db4d82b8ade61b
https://pubmed.ncbi.nlm.nih.gov/27264617
https://pubmed.ncbi.nlm.nih.gov/27264617